[Long-term results of polychemotherapy for Hodgkin's disease in children].
In 1974-2000, 49 patients (up to 15 years), with Hodgkin's disease at different stages, for different reasons, received polychemotherapy alone. Overall 5-year survival was 72.4%; 10 years-64.5%, and 15 years--52.7%. A correlation was established between survival, on the one hand, and stage and general symptoms, on the other: stages--I-IIIA--76.8%; IIIB-IVAB--37.7%; polychemotherapy--6 cycles--67.9%; more than 6 cycles--100%; age up to 10 years--75.8%; more than 10 years--45%.
N.N. Petrov Research Institute of Oncology, Ministry of Health of the RF, St. Petersburg.
B A
BA
Kolygin
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D005260:Female; D005500:Follow-Up Studies; D006689:Hodgkin Disease / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology; D006801:Humans; D007223:Infant; D008297:Male; D009367:Neoplasm Staging; D016019:Survival Analysis; D013997:Time Factors; D016896:Treatment Outcome